Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily vs. Diclofenac 75 mg Twice Daily in Subjects With Acute Low Back Pain

NCT00649610 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00649610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00649610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily vs. Diclofenac 75 mg Twice Daily in Subjects With Acute Low Back Pain
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2002
Completion date
May 31, 2003
Enrollment
340 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain